Document:

exv10w1

 

Exhibit 10.1

AGREEMENT

MAY 24, 2006

     THIS AGREEMENT (this “Agreement”) is made and entered into as of May 24, 2006 (the “Effective
Date”), by and between HealthMarkets, Inc. (formerly UICI), a Delaware corporation (“HealthMarkets”
or the “Company”) and Glenn W. Reed (the “Executive”).

     WHEREAS, as of the date hereof, the Executive serves as the Executive Vice President and
General Counsel of the Company;

     WHEREAS, the Executive is knowledgeable and experienced in certain aspects of the Company’s
business and the Company believes that it benefits from the application of the Executive’s
particular and unique skill, experience and background to the management and operation of the
Company, and that the Executive has made and will continue to make major contributions to the
short- and long-term profitability, growth and financial strength of the Company;

     WHEREAS, the Executive has performed and continues to perform services for the Company as an
employee;

     WHEREAS, the Company desires to continue to employ the Executive, and the Executive desires to
continue to be employed by the Company;

     WHEREAS, the Company and the Executive desire to set forth in this Agreement the terms and
conditions of Executive’s employment with, resignation from and consulting to the Company; and

     WHEREAS, certain terms used herein are defined in Section 26.

     NOW, THEREFORE, in consideration of the premises and of the mutual covenants herein contained,
it is agreed as follows:

     1. Employment.

          (a) Effective as of the Effective Date, the Company hereby agrees to continue to employ the
Executive and the Executive hereby agrees to continue to be employed by the Company upon the terms
and conditions set forth herein.

          (b) The employment relationship between the Company and the Executive shall be governed by the
general employment policies and practices of the Company, including without limitation, those
relating to the Company’s Code of Professional Conduct, confidential information and avoidance of
conflicts; provided, however, that where the terms of this Agreement differ from or
are in conflict with the Company’s general employment policies or practices, the provisions of this
Agreement shall control.

1

 

     2. Term.

          (a) The Company will continue to employ the Executive pursuant to the terms of this Agreement
for a period (the “Employment Term”) commencing as of the Effective Date and ending on June 30,
2006 (the “Termination Date”); provided, however, that the Company and the Executive may agree in
writing to extend the Employment Term for an additional period of time as may be mutually agreed
upon by the parties, in which case, the Termination Date shall be the date such extended Employment
Term ends. Notwithstanding the foregoing, this Agreement may be terminated early by the Executive
upon thirty (30) days’ written notice to the Company.

          (b) For a period commencing on the Termination Date and ending on December 31, 2006 (the
“Consulting Term”), the Executive shall be available twenty (20) hours per month upon request of
the Company to provide consulting services to the Company            Consulting services provided by
the Executive during the Consulting Term in excess of twenty (20) hours per month shall be invoiced
by the Executive to the Company for payment to the Executive at an hourly rate of $200.00 per hour.
The Company will reimburse the Executive for all reasonable travel, lodging, telephone and similar
expenses incurred in connection with the provision of the consulting services contemplated hereby
on substantially the same basis as applies to senior executives of the Company.

     3. Position and Duties of the Executive.

          (a) During the Employment Term, the Executive shall continue to serve as the Executive Vice
President and General Counsel of the Company with the same duties and reporting responsibilities as
the Executive holds immediately prior to the Effective Date.

          (b) Throughout the Employment Term and provided that such activities do not contravene the
provisions of Section 3(a) or Sections 12 and 13 hereof and provided further that the Executive
does not engage in any other substantial business activity for gain, profit or other pecuniary
advantage which materially interferes with the performance of his duties hereunder, the Executive
may participate in any governmental, educational, charitable or other community affairs and serve
as a member of the governing board of any such organization or of up to three (3) private or public
for profit companies, subject in each case to the prior approval of the CEO. The Executive may
retain all fees and other compensation from any such service, and the Company shall not reduce his
compensation by the amount of such fees.

     4. Compensation. During the Employment Term, the Company shall pay to the Executive
an annualized base salary of not less than $400,000 per annum (the “Base Salary”) payable at the
times and in the manner consistent with the Company’s general policies regarding compensation of
executive employees. Such Base Salary shall include any salary reduction contributions to (i) any
Company-sponsored plan that includes a cash-or-deferred arrangement under Section 401(k) of the
Code, (ii) any other plan of deferred compensation sponsored by the Company, or (iii) any
Company-sponsored welfare plans and programs.

     5. Employee Benefits. In addition to the compensation described in Section 4, the
Executive will be eligible to participate in the Company’s employee benefit plans and will be
entitled to receive perquisites, on terms and conditions no less favorable to the Executive than

2

 

those in effect for the Executive immediately prior to the Effective Date, including without
limitation the eligibility rules, (i) participation for the Executive and his eligible dependents
in the Company-sponsored employee benefit plans or arrangements and such other usual and customary
benefits now or hereafter generally available to employees of the Company, and (ii) such benefits
and perquisites as may be made available to similarly situated executives of the Company as a
group, including, without limitation, cash incentive programs, vacations, and retirement, deferred
compensation and welfare plans and financial and tax planning services.

     6. Expenses. The Company shall also pay or reimburse the Executive for reasonable and
necessary expenses incurred by the Executive in connection with his duties on behalf of the Company
in accordance with the expense policy of the Company applicable to members of senior management of
the Company.

     7. Vacation. During the Employment Term, the Executive shall be entitled to a number
of days of vacation (determined ratably on an annual basis) in accordance with the Company’s
policies, whether written or unwritten, regarding vacation for similarly situated executives of the
Company and its Subsidiaries generally. 

     8. Place of Performance. In connection with his employment by the Company, unless
otherwise agreed by the Executive, the Executive shall be based at the principal executive offices
of the Company located in North Richland Hills, Texas, except for travel reasonably required for
Company business.

     9. Resignation from All Positions. Upon the termination of the Executive’s employment
on the Termination Date, the Executive shall immediately resign from all positions, offices,
committees and/or directorships that he holds with the Company, its Subsidiaries and any of their
respective affiliates (and with any other entities with respect to which the Company has requested
the Executive to perform services), as applicable, including, without limitation, all elected
officer and boards of directors’ positions (and committees thereof) immediately prior to the
Termination Date and as listed in Exhibit C attached hereto. The Executive hereby agrees to
execute any and all documentation to effectuate such resignations upon request by the Company, but
he shall be treated for all purposes as having so resigned upon termination of his employment,
regardless of when or whether he executes any such documentation.

     10. Termination Upon the Termination Date. Upon the termination of the Executive’s
employment on the Termination Date, subject to the Executive delivering to the Company a release,
substantially in the form attached hereto as Exhibit A, with all periods for revocation expired and
subject to Section 15, during the Payment Period, the Company shall be obligated to pay to the
Executive such payments and make available the benefits set forth in this Section 10.

          (a) Salary Continuation. The Executive will be entitled to receive the sum of
$1,600,008 in 24 monthly installments of $66,667, (the “Termination Payments”). Termination
Payments shall be paid to the Executive on the last day of each month for the duration of the
Payment Period. If the Executive should die while any amounts are still payable to him hereunder,
all such amounts, unless otherwise provided herein, shall be paid to the Executive’s beneficiary
named for purposes of the Company’s 401(k) and Savings Plan, or, if none, then to the Executive’s
estate, in the form of a lump sum cash payment equal to the amount of the remaining Termination

3

 

Payments not later than the tenth (10th) business day following the Executive’s
death, without reduction for the time value of money.

          (b) Benefit Continuation. In addition to other payments to be made to the Executive
hereunder, the Company shall continue to pay the Company paid portion of the premium for continued
participation in the medical, prescription drug, vision, dental and life insurance coverage, for
the number of insureds and at the level of benefits that the Executive has currently elected to
receive, for the duration of the Payment Period. Participation for the Executive and his eligible
dependents in the Company-sponsored employee benefit plans (outlined above), shall be those plans
currently in place or thereafter generally available to employees of the Company. The Executive
shall be responsible for the payments of the employee paid portion of the insurance premiums
(outlined above), for the duration of the Payment Period.

          (c) COBRA Eligibility. The Executive shall be eligible to apply for COBRA, based on
the terms and conditions of COBRA eligibility, at the conclusion of the Payment Period.

          (d) Office Equipment. The Company agrees that the Executive will have the opportunity
to purchase the Company’s laptop computer and peripheral devices provided for his use during his
Employment Term from the Company at the Company’s unamortized cost.

          (e) No Obligation to Mitigate. The Executive is under no obligation to mitigate
damages or the amount of any payment provided for hereunder by seeking other employment or
otherwise.

     11. Certain Additional Payments by the Company. Anything in this Agreement to the
contrary notwithstanding, in the event that it is determined (as hereafter provided) that any
payment (other than the Gross-Up Payments provided for in this Section 11 and Exhibit B) or
distribution by the Company or any of its affiliates to or for the benefit of the Executive,
whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or
otherwise pursuant to or by reason of any other agreement, policy, plan, program or arrangement,
including any stock option, performance share, performance unit, stock appreciation right or
similar right, or the lapse or termination of any restriction on or the vesting or exercisability
of any of the foregoing (a “Payment”), would be subject to the excise tax imposed by Section 4999
of the Code (or any successor provision thereto) by reason of being considered “contingent on a
change in ownership or control” of the Company, within the meaning of Section 280G of the Code (or
any successor provision thereto) or to any similar tax imposed by state or local law, or any
interest or penalties with respect to such tax (such tax or taxes, together with any such interest
and penalties, being hereafter collectively referred to as the “Excise Tax”), then the Executive
will be entitled to receive an additional payment or payments (collectively, a “Gross-Up Payment”);
except that no Gross-up Payment will be made with respect to the Excise Tax, if any, attributable
to (i) any incentive stock option, as defined by Section 422 of the Code (“ISO”) granted prior to
the execution of this Agreement, or (ii) any stock appreciation or similar right, whether or not
limited, granted in tandem with any ISO described in clause (i). The Gross-Up Payment will be in
an amount such that, after payment by the Executive of all taxes (including any interest or
penalties imposed with respect to such taxes), including any Excise Tax imposed upon the Gross-Up
Payment, the Executive retains an amount of the Gross-Up Payment equal to the Excise Tax imposed
upon the Payment. For purposes of determining the amount of the Gross-Up Payment,

4

 

the Executive will be considered to pay (1) federal income taxes at the highest rate in effect
in the year in which the Gross-Up Payment will be made and (2) state and local income taxes at the
highest rate in effect in the state or locality in which the Gross-Up Payment would be subject to
state or local tax, net of the maximum reduction in federal income tax that could be obtained from
deduction of such state and local taxes. The obligations set forth in this Section 11 will be
subject to the procedural provisions described in Exhibit B.

     12. Confidentiality.

          (a) The Executive acknowledges that in the course of his employment by the Company, he will or
may have access to and become informed of confidential or proprietary information which is a
competitive asset of the Company (“Confidential Information”), including, without limitation, (i)
the terms of any agreement between the Company and any employee, customer or supplier, (ii) pricing
strategy, (iii) merchandising and marketing methods, (iv) product development ideas and strategies,
(v) personnel training and development programs, (vi) financial results, (vii) strategic plans and
demographic analyses, (viii) proprietary computer and systems software, and (ix) any non-public
information concerning the Company, its employees, suppliers or customers. The Executive agrees
that he will keep all Confidential Information in strict confidence during the Employment Term and
thereafter, and will never directly or indirectly make known, divulge, reveal, furnish, make
available, or use any Confidential Information (except in the course of his regular authorized
duties on behalf of the Company). The Executive’s obligations under this Section 12 are in addition
to, and not in limitation of or preemption of, all other obligations of confidentiality which the
Executive may have to the Company under general legal or equitable principles.

          (b) Except in the ordinary course of the Company’s business, the Executive has not made, nor
shall at any time following the date of this Agreement, make or cause to be made, any copies,
pictures, duplicates, facsimiles or other reproductions or recordings or any abstracts or summaries
including or reflecting Confidential Information. All such documents and other property furnished
to the Executive by the Company or otherwise acquired or developed by the Company shall at all
times be the property of the Company. Upon termination of the Executive’s employment with the
Company, the Executive will return to the Company any such documents or other property of the
Company which are in the possession, custody or control of the Executive.

          (c) Without the prior written consent of the Company (which may be withheld for any reason or
no reason), except in the ordinary course of the Company’s business, the Executive shall not at any
time following the date of this Agreement use for the benefit or purposes of the Executive or for
the benefit or purposes of any other person, firm, partnership, association, trust, venture,
corporation or business organization, entity or enterprise or disclose in any manner to any person,
firm, partnership, association, trust, venture, corporation or business organization, entity or
enterprise any Confidential Information.

          (d) The Executive acknowledges and agrees that a violation of the foregoing provisions of this
Section 12 that results in material detriment to the Company would cause irreparable harm to the
Company, and that the Company’s remedy at law for any such violation would be inadequate. In
recognition of the foregoing, the Executive agrees that, in addition to any other relief afforded
by law or this Agreement, including damages sustained by a breach of this

5

 

Agreement and without the necessity or proof of actual damages, the Company shall have the
right to enforce this Agreement by specific remedies, which shall include, among other things,
temporary and permanent injunctions, it being the understanding of the undersigned parties hereto
that damages and injunctions shall all be proper modes of relief and are not to be considered as
alternative remedies.

     13. Covenant Not to Compete; Covenant Not to Solicit. For a period commencing on the
Effective Date and for a period ending two (2) years after the Termination Date, the Executive
agrees that he will not, directly or indirectly, individually or on behalf of any other person or
entity:

          (a) engage in any activity that can be reasonably expected to result in a competitive harm to
the Company or any of the Company’s Subsidiaries or affiliates (collectively, the “Company Group”)
in any region of the United States in which such business is being conducted; or

          (b) solicit for hire, hire or employ (whether as an officer, director or insurance agent) any
person who is an employee or independent contractor of any member of the Company Group or has been
an employee or independent contractor of any member of the Company Group at any time during the
six-month period prior to the Executive’s termination of employment or solicit, aid or induce any
such person to leave his or his employment with any member of the Company Group to accept
employment with any other person or entity. 

Executive’s ownership of less than five percent (5%) of any class of stock in a publicly-traded
corporation shall not be deemed a breach of this Section 13.

     14. Legal Fees. The Company will pay or reimburse the Executive, as incurred, all
legal fees and costs incurred by the Executive in enforcing his rights under the Agreement, if the
Executive’s position substantially prevails.

     15. Compliance with Section 409A of the Code. This Agreement is intended to comply
and shall be administered in a manner that is intended to comply with Section 409A of the Code and
shall be construed and interpreted in accordance with such intent. To the extent that a payment
and/or benefit is subject to Section 409A of the Code, it shall be paid in a manner that will
comply with Section 409A of the Code, including proposed, temporary or final regulations or any
other guidance issued by the Secretary of the Treasury and the Internal Revenue Service with
respect thereto (the “Guidance”). Any provision of this Agreement that would cause a payment
and/or benefit to fail to satisfy Section 409A of the Code shall have no force and effect until
amended to comply with Code Section 409A (which amendment may be retroactive to the extent
permitted by the Guidance).

     16. No Prior Agreement. Each party to this Agreement acknowledges that, as of the Effective
Date, no prior valid or binding representations, inducements, promises, or other agreements, orally
or otherwise, have been made by any party, or anyone acting on behalf of any party, pertaining to
the subject matter hereof.

     17. Withholding of Taxes. The Company may withhold from any amounts payable or
transfer made under any compensation or other amount owing to the Executive under this

6

 

Agreement all applicable federal, state, city or other withholding taxes as the Company is
required to withhold pursuant to any law or government regulation or ruling.

     18. Successors and Binding Agreement.

          (a) The Company will require any successor (whether direct or indirect, by purchase, merger,
consolidation, reorganization or otherwise) to all or substantially all of the business or assets
of the Company, by agreement in form and substance satisfactory to the Executive, expressly to
assume and agree to perform this Agreement in the same manner and to the same extent the Company
would be required to perform if no such succession had taken place. This Agreement will be binding
upon and inure to the benefit of the Company and any successor to the Company, including without
limitation any persons acquiring directly or indirectly all or substantially all of the business or
assets of the Company whether by purchase, merger, consolidation, reorganization or otherwise (and
such successor shall thereafter be deemed the “Company” for the purposes of this Agreement), but
will not otherwise be assignable, transferable or delegable by the Company.

          (b) This Agreement will inure to the benefit of and be enforceable by the Executive’s personal
or legal representatives, executors, administrators, successors, heirs, distributees and legatees.

          (c) This Agreement is personal in nature and neither of the parties hereto shall, without the
consent of the other, assign, transfer or delegate this Agreement or any rights or obligations
hereunder except as expressly provided in Sections 18(a) and 18(b). Without limiting the
generality or effect of the foregoing, the Executive’s right to receive payments hereunder will not
be assignable, transferable or delegable, whether by pledge, creation of a security interest, or
otherwise, other than by a transfer by the Executive’s will or by the laws of descent and
distribution and, in the event of any attempted assignment or transfer contrary to this Section
18(c), the Company shall have no liability to pay any amount so attempted to be assigned,
transferred or delegated.

     19. Notices. For all purposes of this Agreement, all communications, including
without limitation notices, consents, requests or approvals, required or permitted to be given
hereunder will be in writing and will be deemed to have been duly given when hand delivered or
dispatched by electronic facsimile transmission (with receipt thereof confirmed), or five (5)
business days after having been mailed by United States registered or certified mail, return
receipt requested, postage prepaid, or three business days after having been sent by a nationally
recognized overnight courier service such as Federal Express, UPS, or Purolator, addressed to the
Company (to the attention of the Secretary of the Company) at its principal executive offices and
to the Executive at his principal residence, or to such other address as any party may have
furnished to the other in writing and in accordance herewith, except that notices of changes of
address shall be effective only upon receipt.

     20. Governing Law. The validity, interpretation, construction and performance of this
Agreement will be governed by and construed in accordance with the substantive laws of the State of
Delaware, without giving effect to the principles of conflict of laws of such State.

7

 

     21. Indemnification. The Company will indemnify the Executive (and his legal
representative or other successors) to the fullest extent permitted (including a payment of
expenses in advance of final disposition of a proceeding) by applicable law, as in effect at the
time of the subject act or omission, or by the Certificate of Incorporation and By-Laws of the
Company, as in effect at such time or on the Commencement Date, or by the terms of any
indemnification agreement between the Company and the Executive, whichever affords or afforded
greatest protection to the Executive, and the Executive shall be entitled to the protection of any
insurance policies the Company may elect to maintain generally for the benefit of its directors and
officers (and to the extent the Company maintains such an insurance policy or policies, the
Executive shall be covered by such policy or policies, in accordance with its or their terms to the
maximum extent of the coverage available for any Company officer or director), against all costs,
charges and expenses whatsoever incurred or sustained by him or his legal representatives
(including but not limited to any judgment entered by a court of law) at the time such costs,
charges and expenses are incurred or sustained, in connection with any action, suit or proceeding
to which the Executive (or his legal representatives or other successors) may be made a party by
reason of his having accepted employment with the Company or by reason of his being or having been
a director, officer or employee of the Company, or any subsidiary of the Company, or his serving or
having served any other enterprise as a director, officer or employee at the request of the
Company. The Executive’s rights under this Section 21 shall continue without time limit for so
long as he may be subject to any such liability, whether or not the Employment Term may have ended.

     22. Validity. If any provision of this Agreement or the application of any provision
hereof to any person or circumstances is held invalid, unenforceable or otherwise illegal, the
remainder of this Agreement and the application of such provision to any other person or
circumstances will not be affected, and the provision so held to be invalid, unenforceable or
otherwise illegal will be reformed to the extent (and only to the extent) necessary to make it
enforceable, valid or legal.

     23. Survival of Provisions. Notwithstanding any other provision of this Agreement,
the parties’ respective rights and obligations under Sections 9, 10, 11, 12, 13 and 20 will survive
any termination or expiration of this Agreement or the termination of the Executive’s employment
for any reason whatsoever.

     24. Miscellaneous. No provision of this Agreement may be modified, waived or
discharged unless such waiver, modification or discharge is agreed to in writing signed by the
Executive and the Company. No waiver by either party hereto at any time of any breach by the other
party hereto or compliance with any condition or provision of this Agreement to be performed by
such other party will be deemed a waiver of similar or dissimilar provisions or conditions at the
same or at any prior or subsequent time. Unless otherwise noted, references to “Sections” are to
sections of this Agreement. The captions used in this Agreement are designed for convenient
reference only and are not to be used for the purpose of interpreting any provision of this
Agreement.

     25. Company Acknowledgment. The Company acknowledges by entering into this Agreement
that it has obtained all corporate and other approvals necessary to enter into and fully perform
its obligations hereunder.

8

 

     26. Defined Terms.

          (a) “Agreement” has the meaning specified in the introductory paragraph of this Agreement.

          (b) “Base Salary” has the meaning specified in Section 4.

          (c) “Board” means the Board of Directors of the Company.

          (d) “CEO” means the Chief Executive Officer of the Company.

          (e) “COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1985.

          (f) “Code” means the Internal Revenue Code of 1986, as amended.

          (g) “Committee” means the Executive Compensation Committee of the Board.

          (h) “Company” has the meaning specified in the introductory paragraph of this Agreement.

          (i) “Company Group” has the meaning specified in Section 13(a).

          (j) “Confidential Information” has the meaning specified in Section 12.

          (k) “Consulting Term” has the meaning specified in Section 2(b).

          (l) “Effective Date” has the meaning specified in the introductory paragraph of this
Agreement.

          (m) “Employment Term” has the meaning specified in Section 2(a).

          (n) “401(k) Plan” means the Company’s 401(k) and Savings Plan.

          (o) “Excise Tax” has the meaning specified in Section 11.

          (p) “Executive” has the meaning specified in the introductory paragraph of this Agreement.

          (q) “Gross-Up Payment” has the meaning specified in Section 11.

          (r) “Guidance” has the meaning specified in Section 15.

          (s) “HealthMarkets” has the meaning specified in the introductory paragraph of this Agreement.

          (t) “HealthMarkets Affiliates” has the meaning specified in paragraph 1 of Exhibit A.

9

 

          (u) “ISO” has the meaning specified in Section 11.

          (v) “National Firm” has the meaning specified in Section 10(a).

          (w) “Payment” has the meaning specified in paragraph 1 of Exhibit B.

          (x) “Payment Period” means the two-year period following the Executive’s Termination Date.

          (y) “Release” has the meaning specified in the introductory paragraph of Exhibit A.

          (z) “Revocation Date” has meaning specified in paragraph 3 of Exhibit A.

          (aa) “Subsidiary” shall mean any entity, corporation, partnership (general or limited),
limited liability company, entity, firm, business organization, enterprise, association or joint
venture in which the Company directly or indirectly controls ten percent (10%) or more of the
voting interest.

          (bb) “Termination Date” has the meaning specified in Section 2(a).

          (cc) “Termination Payments” has the meaning specified in Section 10(a).

          (dd) “Underpayment” has the meaning specified in paragraph 1 of Exhibit B.

     27. Counterparts. This Agreement may be executed in one or more counterparts, each of
which shall be deemed to be an original but all of which together will constitute one and the same
agreement.

10

 

     IN WITNESS WHEREOF, with the Company signatory listed below having been duly authorized by the
Company to enter into this Agreement by the Company, the parties hereto have executed this
Agreement as of the day and year first written.

	 	 	 	 	 
	 	 	 
	 	/s/ Glenn W. Reed
 	 
	 	Glenn W. Reed 	 
	 	 	 
	 
	 	HealthMarkets, Inc.

 	 
	 	By:  	/s/ William J. Gedwed
 	 
	 	 	William J. Gedwed 	 
	 	 	President and CEO 	 

11

 

	 	 	 	 	 

Exhibit A

Form of Release

          In consideration of the payments and promises contained in your Agreement with the Company
dated May ___, 2006, and in full compromise and settlement of any of your potential claims and
causes of action relating to or arising out of your employment relationship with HealthMarkets or
the termination of that relationship, and any and all other claims or causes of action that you
have or may have against the HealthMarkets Affiliates (as defined below) up to the date of
execution of this release (the “Release”), you hereby:

     1. knowingly and voluntarily agree to irrevocably and unconditionally waive and release
HealthMarkets and any other entity controlled by, controlling or under common control with
HealthMarkets, and their predecessors and successors and directors, officers, employees,
representatives, attorneys, including all persons acting by, through, under or in concert with any
of them (collectively, the “HealthMarkets Affiliates”), from any and all charges, complaints,
claims, liabilities, obligations, promises, sums of money, agreements, controversies, damages,
actions, lawsuits, rights, demands, sanctions, costs (including attorneys’ fees), losses, debts and
expenses of any nature whatsoever, existing on, or at any time prior to, the date hereof in law, in
equity or otherwise, which you, your successors, heirs or assigns had or have upon or by reason of
any fact, matter, cause, or thing whatsoever, and specifically including any matter that may be
based on the sole or contributory negligence (whether active, passive or gross) of any
HealthMarkets Affiliate. This release includes, but is not limited to, a release of all claims or
causes of action arising out of or relating to your employer-employee relationship with
HealthMarkets or the termination of that relationship, and any other claim, including, without
limitation, alleged breach of express or implied written or oral contract, alleged breach of
employee handbook, alleged wrongful discharge, and tort claims, or claims or causes of action
arising under any federal, state, or local law, including, but not limited to, the Age
Discrimination in Employment Act, 29 U.S.C. § 621, et seq., the Reconstruction Era Civil Rights Act
of 1866 and 1871, 42 U.S.C. §§ 1981 and 1983, the Civil Rights Act of 1964, Title VII, 42 U.S.C. §§
2000(e) et seq., The Civil Rights Act of 1991, 42 U.S.C. § 1981(a) et seq., the Equal Pay Act of
1963, 29 U.S.C. § 206(d) et seq., the Americans with Disabilities Act of 1990, 42 U.S.C. §§ 12101
et seq. the Rehabilitation Act of 1973, 29 U.S.C. § 701 et seq., the Worker Adjustment and
Retraining Notification Act, 29 U.S.C. §§ 2101-2109, the Sarbanes-Oxley Act of 2002, as amended,
[state-specific employee-employer laws] and any claim under any other statutes of the State of
Texas, or other jurisdictions, and the facts, circumstances, allegations, and controversies
relating or giving rise thereto that have accrued to the date of execution of this Release; and

     2. agree that you will not commence, maintain, initiate, or prosecute, or cause, encourage,
assist, volunteer, advise or cooperate with any other person to commence, maintain, initiate or
prosecute, any action, lawsuit, proceeding, investigation, or claim before any court, legislative
body or committee, or administrative agency (whether state, federal or otherwise) against the
HealthMarkets Affiliates relating to any claims, liabilities, obligations, promises, sums of money,
agreements, controversies, damages, actions, lawsuits, rights, demands, sanctions, costs

A-1

 

(including attorneys’ fees), losses, debts and expenses described in the foregoing Paragraph
1; provided, however, that, notwithstanding anything to the contrary in the
foregoing, nothing hereunder shall be deemed to affect, impair or diminish in any respect (i) any
vested rights as of the date of termination or entitlement you may have under the 401(k) Plan; (ii)
any other vested rights as of the date of termination you may have under any employee plan or
program in which you have participated in your capacity as an employee of the Company or any other
HealthMarkets Affiliate; (iii) your right to seek to collect unemployment benefits that you may be
entitled to as a result of your employment with the Company or your right to seek benefits under
workers’ compensation insurance, if applicable; (iv) your rights under this Release; including but
not limited to your right to bring a claim for breach of this Release; (v) any rights you may have
under Section 21 (Indemnification) of the Agreement and that certain Indemnification Agreement,
dated as of ___, ___between you and HealthMarkets (which Indemnification Agreement
HealthMarkets, by its signature hereto, confirms shall remain            in full force and effect
in accordance with the terms thereof); (vi) any rights to indemnification that you have or may have
under the terms of the HealthMarkets Amended and Restated Bylaws; or (vii) your right to bring a
claim under the Age Discrimination in Employment Act to challenge the validity of this Release, to
file a charge under the civil rights statutes, or to otherwise participate in an investigation or
proceeding conducted by the Equal Employment Opportunity Commission or other investigative
agency.;

     3. acknowledge that: (i) this entire Release is written in a manner calculated to be
understood by you; (ii) you have been advised to consult with an attorney before executing this
Release; (iii) you were given a period of twenty-one days within which to consider this Release;
and (iv) to the extent you execute this Release before the expiration of the twenty-one-day period,
you do so knowingly and voluntarily and only after consulting your attorney. You shall have the
right to cancel and revoke this Release during a period of seven days following the date on which
you execute it, and this Release shall not become effective, and no money will be paid to you in
respect of severance, until the day after the expiration of such seven-day period (the “Revocation
Date”). In order to revoke this Release, you shall deliver to the Company, prior to the expiration
of said seven-day period, a written notice of revocation. Upon such revocation, this Release shall
be null and void and of no further force or effect;

     4. agree to make yourself reasonably available to HealthMarkets following the date of your
termination to assist the HealthMarkets Affiliates, as may be requested by HealthMarkets at
mutually convenient times and places, with respect to the business of HealthMarkets and pending and
future litigations, arbitrations, governmental investigations or other dispute resolutions relating
to or in connection with HealthMarkets; and

     5. agree not to, either in writing or by any other medium, make any disparaging or derogatory
statement about the HealthMarkets Affiliates or any of their respective officers, directors,
employees, affiliates, Subsidiaries, successors, assigns or businesses, as the case may be;
provided, however, that you may make such statements as are necessary to comply with law.

A-2

 

Exhibit B

EXCISE TAX GROSS-UP PROCEDURAL PROVISIONS

     1. Subject to the provisions of Paragraph 5, all determinations required to be made under
Section 11 of the Agreement and Exhibit B, including whether an Excise Tax is payable by the
Executive and the amount of such Excise Tax and whether a Gross-Up Payment is required to be paid
by the Company to the Executive and the amount of such Gross-Up Payment, if any, will be made by a
nationally recognized accounting firm (the “National Firm”) selected by the Executive in the
Executive’s sole discretion. The Executive will direct the National Firm to submit its
determination and detailed supporting calculations to both the Company and the Executive within
thirty (30) calendar days after the date of termination of the Executive’s employment, if
applicable, and any such other time or times as may be requested by the Company or the Executive.
If the National Firm determines that any Excise Tax is payable by the Executive, the Company will
pay the required Gross-Up Payment to the Executive within five (5) business days after receipt of
such determination and calculations with respect to any Payment to the Executive. If the National
Firm determines that no Excise Tax is payable by the Executive with respect to any material benefit
or amount (or portion thereof), it will, at the same time as it makes such determination, furnish
the Company and the Executive with an opinion that the Executive has substantial authority not to
report any Excise Tax on Executive’s federal, state or local income or other tax return with
respect to such benefit or amount. As a result of the uncertainty in the application of Section
4999 of the Code and the possibility of similar uncertainty regarding applicable state or local tax
law at the time of any determination by the National Firm hereunder, it is possible that Gross-Up
Payments that will not have been made by the Company should have been made (an “Underpayment”),
consistent with the calculations required to be made hereunder. In the event that the Company
exhausts or fails to pursue its remedies pursuant to Paragraph 5 and the Executive thereafter is
required to make a payment of any Excise Tax, the Executive will direct the National Firm to
determine the amount of the Underpayment that has occurred and to submit its determination and
detailed supporting calculations to both the Company and the Executive as promptly as possible.
Any such Underpayment will be promptly paid by the Company to, or for the benefit of, the Executive
within five (5) business days after receipt of such determination and calculations.

     2. The Company and the Executive will each provide the National Firm access to and copies of
any books, records and documents in the possession of the Company or the Executive, as the case may
be, reasonably requested by the National Firm, and otherwise cooperate with the National Firm in
connection with the preparation and issuance of the determinations and calculations contemplated by
Paragraph 1. Any determination by the National Firm as to the amount of the Gross-Up Payment will
be binding upon the Company and the Executive.

     3. The federal, state and local income or other tax returns filed by the Executive will be
prepared and filed on a consistent basis with the determination of the National Firm with respect
to the Excise Tax payable by the Executive. The Executive will report and make proper payment of
the amount of any Excise Tax, and at the request of the Company, provide to the Company true

B-1

 

and correct copies (with any amendments) of the Executive’s federal income tax return as filed
with the Internal Revenue Service and corresponding state and local tax returns, if relevant, as
filed with the applicable taxing authority, and such other documents reasonably requested by the
Company, evidencing such payment. If prior to the filing of the Executive’s federal income tax
return, or corresponding state or local tax return, if relevant, the National Firm determines that
the amount of the Gross-Up Payment should be reduced, the Executive will within five (5) business
days pay to the Company the amount of such reduction.

     4. The fees and expenses of the National Firm for its services in connection with the
determinations and calculations contemplated by Paragraph 1 will be borne by the Company. If such
fees and expenses are initially paid by the Executive, the Company will reimburse the Executive the
full amount of such fees and expenses within five (5) business days after receipt from the
Executive of a statement therefore and reasonable evidence of Executive’s payment thereof.

     5. The Executive will notify the Company in writing of any claim by the Internal Revenue
Service or any other taxing authority that, if successful, would require the payment by the Company
of a Gross-Up Payment. Such notification will be given as promptly as practicable but no later
than 10 business days after the Executive actually receives notice of such claim and the Executive
will further apprise the Company of the nature of such claim and the date on which such claim is
requested to be paid (in each case, to the extent known by the Executive). The Executive will not
pay such claim prior to the expiration of the 30-calendar-day period following the date on which
Executive gives such notice to the Company or, if earlier, the date that any payment of amount with
respect to such claim is due. If the Company notifies the Executive in writing prior to the
expiration of such period that it desires to contest such claim, the Executive will:

          (a) provide the Company with any written records or documents in Executive’s possession
relating to such claim reasonably requested by the Company;

          (b) take such action in connection with contesting such claim as the Company reasonably
requests in writing from time to time, including without limitation accepting legal representation
with respect to such claim by an attorney competent in respect of the subject matter and reasonably
selected by the Company;

          (c) cooperate with the Company in good faith in order effectively to contest such claim; and

          (d) permit the Company to participate in any proceedings relating to such claim;

provided, however, that the Company will bear and pay directly all costs and
expenses (including interest and penalties) incurred in connection with such contest and will
indemnify and hold harmless the Executive, on an after-tax basis, for and against any Excise Tax or
income or other tax, including interest and penalties with respect thereto, imposed as a result of
such representation and payment of costs and expenses. Without limiting the foregoing provisions
of this Paragraph 5, the Company will control all proceedings taken in connection with the contest
of any claim contemplated by this Paragraph 5 and, at its sole option, may pursue or forego any and
all

B-2

 

administrative appeals, proceedings, hearings and conferences with the taxing authority in respect
of such claim (provided, however, that the Executive may participate therein at
Executive’s own cost and expense) and may, at its option, either direct the Executive to pay the
tax claimed and sue for a refund or contest the claim in any permissible manner, and the Executive
agrees to prosecute such contest to a determination before any administrative tribunal, in a court
of initial jurisdiction and in one or more appellate courts, as the Company determines; provided,
however, that if the Company directs the Executive to pay the tax claimed and sue for a refund, the
Company will advance the amount of such payment to the Executive on an interest-free basis and will
indemnify and hold the Executive harmless, on an after-tax basis, from any Excise Tax or income or
other tax, including interest or penalties with respect thereto, imposed with respect to such
advance; and provided further, however, that any extension of the statute of
limitations relating to payment of taxes for the taxable year of the Executive with respect to
which the contested amount is claimed to be due is limited solely to such contested amount.
Furthermore, the Company’s control of any such contested claim will be limited to issues with
respect to which a Gross-Up Payment would be payable hereunder, and the Executive will be entitled
to settle or contest, as the case may be, any other issue raised by the Internal Revenue Service or
any other taxing authority.

     6. If, after the receipt by the Executive of an amount advanced by the Company pursuant to
Paragraph 5, the Executive receives any refund with respect to such claim, the Executive will
(subject to the Company’s complying with the requirements of Paragraph 5) promptly pay to the
Company the amount of such refund (together with any interest paid or credited thereon after any
taxes applicable thereto). If, after the receipt by the Executive of an amount advanced by the
Company pursuant to Paragraph 5, a determination is made that the Executive is not entitled to any
refund with respect to such claim and the Company does not notify the Executive in writing of its
intent to contest such denial or refund prior to the expiration of 30 calendar days after such
determination, then such advance will be forgiven and will not be required to be repaid and the
amount of any such advance will offset, to the extent thereof, the amount of Gross-Up Payment
required to be paid by the Company to the Executive pursuant to Section 11 and this Exhibit B.

B-3

 

Exhibit C

CORPORATE OFFICERSHIPS AND DIRECTORSHIPS

GLENN W. REED

	 	 	 
	CORPORATION	 	POSITION
	 
	 	 
	HealthMarkets, Inc.

	 	Executive Vice President and
General Counsel
	 
	 	 
	The Chesapeake Life Insurance Company

	 	Director, Vice President
	 
	 	 
	The MEGA Life and Health Insurance Company

	 	Director, Vice President
	 
	 	 
	Mid-West National Life Insurance Company
of Tennessee

	 	Director, Vice President
	 
	 	 
	Fidelity First Insurance Company

	 	Director, Vice President
	 
	 	 
	AMLI Realty Co.

	 	Director, Vice President and
Treasurer
	 
	 	 
	Performance Driven Awards, Inc.

	 	Director, Vice President
	 
	 	 
	Success Driven Awards, Inc.

	 	Director
	 
	 	 
	UICI Funding Corp. 2

	 	Director, President
	 
	 	 
	UICI Acquisition Co.

	 	Director, President
	 
	 	 
	CFLD-I, Inc.

	 	Director, President
	 
	 	 
	HealthMarket Administrative Services Inc.

	 	Director, President

C-1exv10w2

 

Exhibit 10.2

TERMINATION AGREEMENT

     This Agreement, dated
 as of May 19, 2006 is by and between Special Investment Risks,
Limited, a Texas limited partnership (successor to United Group Association, Inc.) (“SIR”), and HealthMarkets, Inc.
(formerly UICI), a Delaware corporation (“HealthMarkets”).

     WHEREAS, SIR and HealthMarkets have entered into that certain Sale of Assets Agreement dated
March 3, 1997, as amended by Amendments Nos. 1, 2, 3 and 4 thereto (as amended, the “Asset Sale
Agreement”);

     WHEREAS, pursuant to the terms of the Asset Sale Agreement, effective as of January 1, 1997,
SIR transferred and sold to HealthMarkets substantially all of the equipment, fixed assets and
contracts associated with SIR’s former United Group Agency, a general insurance agency that
formerly marketed and sold health insurance policies (a) issued by insurance subsidiaries of AEGON
USA and coinsured by insurance subsidiaries of the Company and (b) previously issued directly by
insurance subsidiaries of the Company;

     WHEREAS, for and in partial consideration for the transfer made in accordance with the Asset
Sale Agreement, (i) SIR retained the right to receive all commissions on policies marketed and sold
by SIR and written prior to January 1, 1997 (including policies previously issued by insurance
subsidiaries of AEGON USA and coinsured by insurance subsidiaries of the Company and policies
previously issued directly by the insurance subsidiaries of the Company) and (ii), with respect to
policies marketed and sold by SIR and written after January 1, 1997, HealthMarkets agreed to pay to
SIR 120 basis points (1.20%) times the UGA Commissionable Renewal Premium Revenue (as such term is
defined in the Asset Sale Agreement) collected in any period (such streams of payments owing to SIR
herein collectively referred to as the “Future Obligation.”)

     WHEREAS, SIR and HealthMarkets desire to discharge in full the Future Obligation and terminate
the Asset Sale Agreement.

     NOW, THEREFORE, for and in consideration of the mutual covenants herein contained, the Seller
and the Purchaser hereby agree as follows:

     1.     Definitions. Unless otherwise defined herein, the following capitalized terms
shall have the specific meaning hereinafter set forth:

     “Effective Date” shall mean May 19, 2006.

     "Governmental Authority” means any nation or government, any state or political subdivision
thereof and any entity exercising executive, legislative, judicial, regulatory, or administrative
functions of or pertaining to government.

     "Material Adverse Effect” with respect to any Person means the occurrence of any event or the
existence of any condition that reasonably could be expected to have a material adverse effect on
(a) the business, financial condition or results of operations of such Person, or (b) the validity
or enforceability of this Agreement or the rights and remedies of such Person hereunder.

     “MEGA” shall mean The MEGA Life and Health Insurance Company, an Oklahoma-domiciled health and
life insurance company and indirect, wholly-owned subsidiary of HealthMarkets.

 

 

     “Mid-West” shall mean Mid-West National Life Insurance Company of Tennessee, a Texas-domiciled
health and life insurance company and indirect, wholly-owned subsidiary of HealthMarkets.

     "Person” shall mean means any individual, corporation, business trust, association, company,
partnership, joint venture, Governmental Authority, or other entity

     2.     
Discharge of Future Obligation; Closing. Upon the terms and, subject to the
conditions of this Agreement, on the Closing Date (a) HealthMarkets shall pay to SIR or,
alternatively, HealthMarkets shall cause MEGA and/or Mid-West to pay to SIR, an aggregate of
$47,500,000 (the “Consideration”), (b) the Future Obligation shall be discharged in full, (c) SIR
shall release HealthMarkets, MEGA and Mid-West from any and all liability of HealthMarkets, MEGA or
Mid-West, as the case may be, under the Asset Purchase Agreement, and (c) the Asset Purchase
Agreement shall terminate and be of no further force or effect. The closing of the transaction
contemplated hereby (the “Closing”) shall be consummated at 11:00 a.m. local time on May 19, 2006
or the date on which the last of the conditions specified in Section 5 hereof is satisfied or
waived, whichever is later, at the offices of HealthMarkets, at 9151 Boulevard 26, North Richland
Hills, TX, or at such other time or place as shall be agreed upon by HealthMarkets and SIR. The
time and date on which the Closing is actually held is referred to herein as the “Closing Date.”
The Closing shall be effective as of the Effective Date.

     3.     Termination of Asset Sale Agreement. At and upon the Closing, any and all
obligations of HealthMarkets, MEGA and/or Mid-West under the Asset Sale Agreement shall be deemed
discharged in full, and the Asset Sale Agreement shall be terminated and without further force or
effect.

     4.     Representations and Warranties.

     4.1.  Representations of SIR. SIR represents and warrants to HealthMarkets as follows:

       4.1.1. SIR is a corporation duly organized, validly existing and in good standing under
the laws of Nevada and has all requisite power and authority to own its assets and carry on
its business as now being or as proposed to be conducted.

       4.1.2. SIR has the power and authority and legal right to execute and deliver this
Agreement and to perform its obligations hereunder.

       4.1.3. This Agreement constitutes the legal, valid and binding obligation of SIR,
enforceable against SIR in accordance with its terms, except as limited by bankruptcy,
insolvency or other laws of general application relating to the enforcement of creditors’
rights and general principles of equity.

     4.2.     Representations and Warranties of HealthMarkets. HealthMarkets represents and
warrants to SIR as follows:

       4.2.1. HealthMarkets is a corporation duly organized, validly existing and in good
standing under the laws of the State of Delaware and has all requisite power and authority
to own its assets and carry on its business as now being or as proposed to be conducted.

       4.2.2. HealthMarkets has the power and authority and legal right to execute and deliver
this Agreement and to perform its obligations hereunder.

       4.2.3. This Agreement constitutes the legal, valid and binding obligation of
HealthMarkets, enforceable against HealthMarkets in accordance with its terms, except as
limited

- 2 -

 

by bankruptcy, insolvency or other laws of general application relating to the
enforcement of creditors’ rights and general principles of equity.

     5.     Closing Conditions.

     5.1.  The obligation of HealthMarkets to consummate the transactions contemplated hereby on the
Closing Date is subject to satisfaction of each of the following conditions:

       5.1.1. No order, judgment or decree of any court, arbitrator or Governmental Authority
shall purport or threaten to enjoin or restrain any of the transactions contemplated hereby.

       5.1.2. All of the representations and warranties contained in Section 4.1 hereof shall
be true, correct and complete in all respects on and as of the Closing Date with the same
force and effect as if such representations and warranties had been made on and as of such
date except for any representation or warranty limited by its terms to a specific date.

       5.1.3. No event shall have occurred which shall reasonably be expected to have a
Material Adverse Effect on HealthMarkets.

     5.2.     The obligation of SIR to consummate the transactions contemplated hereby on the Closing
Date is subject to satisfaction of each of the following conditions:

       5.2.1. No order, judgment or decree of any court, arbitrator or Governmental Authority
shall purport or threaten to enjoin or restrain any of the transactions contemplated hereby.

       5.2.2. All of the representations and warranties contained in Section 4.2 hereof shall
be true, correct and complete in all respects on and as of the Closing Date with the same
force and effect as if such representations and warranties had been made on and as of such
date except for any representation or warranty limited by its terms to a specific date.

       5.2.3. No event shall have occurred which shall reasonably be expected to have a
Material Adverse Effect.

     6.     Indemnification.

     6.1.  Indemnification by HealthMarkets. HealthMarkets agrees to indemnify and hold
harmless SIR and its directors, officers, successors, agents, employees, partners, representatives,
heirs, assigns, affiliates and subsidiaries (collectively, a “SIR Indemnified Party”) harmless from
and against any and all from and against any and all losses, damages (including, without
limitation, actual damages, compensatory damages, punitive damages and extra-contractual damages),
liabilities, penalties, regulatory fines, costs and expenses (including, without limitation,
attorneys’ fees, investigation costs and all other reasonable costs associated with the defense
thereof) (collectively, “Losses”), as incurred, arising out of or relating to (a) a breach of any
of the respective covenants or agreements to be performed by HealthMarkets hereunder; and (b)
breaches of any representation or warranty made by HealthMarkets hereunder.

     6.2.  Indemnification by SIR. SIR agrees to indemnify and hold harmless HealthMarkets
and its directors, members, officers, successors, agents, employees, partners, representatives,
heirs, assigns, affiliates and subsidiaries harmless from and against any and all Losses, as
incurred, arising out of or relating to (a) a breach of any of the respective covenants or
agreements to be performed by SIR hereunder; and (b) breaches of any representation or warranty
made by SIR hereunder.

- 3 -

 

     6.3.  Conduct of Indemnification Proceedings.

       6.3.1. If any proceeding shall be brought or asserted against any person entitled to
indemnification hereunder (an “Indemnified Party”), such Indemnified Party promptly shall
notify the person from whom indemnity is sought (the “Indemnifying Party”) in writing, and
the Indemnifying Party shall assume the defense thereof, including the employment of counsel
reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof; provided, however, that the failure of any
Indemnified Party to give such notice shall not relieve the Indemnifying Party of its
obligations or liabilities pursuant to this Agreement, except (and only) to the extent that
it shall be finally determined by a court of competent jurisdiction (which determination is
not subject to appeal or further review) that such failure shall have proximately and
materially adversely prejudiced the Indemnifying Party.

       6.3.2. An Indemnified Party shall have the right to employ separate counsel in any such
proceeding and to participate in the defense thereof, but the fees and expenses of such
counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the
Indemnifying Party has agreed in writing to pay such fees and expenses; (2) the Indemnifying
Party shall have failed promptly to assume the defense of such Proceeding and to employ
counsel reasonably satisfactory to such Indemnified Party in any such Proceeding; or (3) the
named parties to any such proceeding (including any impleaded parties) include both such
Indemnified Party and the Indemnifying Party, and such Indemnified Party shall have been
advised by counsel that a conflict of interest is likely to exist if the same counsel were
to represent such Indemnified Party and the Indemnifying Party (in which case, if such
Indemnified Party notifies the Indemnifying Party in writing that it elects to employ
separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not
have the right to assume the defense thereof and such counsel shall be at the reasonable
expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any
settlement of any such proceeding effected without its written consent, which consent shall
not be unreasonably withheld. No Indemnifying Party shall, without the prior written
consent of the Indemnified Party, effect any settlement of any pending proceeding in respect
of which any Indemnified Party is a party, unless such settlement includes an unconditional
release of such Indemnified Party from all liability on claims that are the subject matter
of such proceeding.

       6.3.3. All fees and expenses of the Indemnified Party (including reasonable fees and
expenses to the extent incurred in connection with investigating or preparing to defend such
proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified
Party, as incurred, within ten (10) business days of a detailed written notice thereof to
the Indemnifying Party (regardless of whether it is ultimately determined that an
Indemnified Party is not entitled to indemnification hereunder; provided, that the
Indemnifying Party may require such Indemnified Party to undertake to reimburse all such
fees and expenses to the extent it is finally judicially determined that such Indemnified
Party is not entitled to indemnification hereunder).

     7.     General Matters.

     7.1.  Any notice, request, instruction or other document to be given hereunder shall be in
writing and: (a) delivered personally; (b) sent by Federal Express or other similarly reputable
overnight courier; or (c) transmitted by facsimile, according to the instructions set forth below.
Such notices shall be sent to the following addresses and/or facsimile numbers and shall be deemed
given: (w) if delivered personally, at the time delivered; (x) if sent by Federal Express or other
similarly reputable overnight

- 4 -

 

courier, at the time sent, or (y) if transmitted by facsimile, at the time when receipt is
confirmed by the sending facsimile machine.

If to SIR, to:

Special
Investment Risks, Limited

C/o JFO Group

6500 Belt Line

Suite 170

Irving, TX 75063-6049

Attn:     Jeffrey J. Jensen

If to HealthMarkets, to:

HealthMarkets, Inc.

9151 Boulevard 26

North Richland Hills, TX 76180

			
	Attention:	 	William J. Gedwed

President

or to such other address as such party may indicate by a notice delivered to the other parties
hereto in accordance with the provisions of this Section 7.1.

     7.2.  This Agreement contains the entire understanding of the parties hereto with regard to the
subject matter contained herein or therein, and supersedes all prior written or oral agreements,
understandings or letters of intent between or among any of the parties hereto. This Agreement
shall not be amended, modified or supplemented except by a written instrument signed by an
authorized representative of each of the parties hereto.

     7.3.  The rights of each party under this Agreement shall not be assignable without the written
consent of each of the other parties.

     7.4.  This Agreement shall be binding upon and inure to the benefit of the parties hereto and
their successors and permitted assigns. Nothing in this Agreement, expressed or implied, is
intended or shall be construed to confer upon any Person other than the parties and successors and
assigns permitted by this Section 7.4 any right, remedy or claim under or by reason of this
Agreement.

     7.5.  Headings to sections herein are inserted for convenience of reference only and are not
intended to be part of or to affect the meaning or interpretation of this Agreement.

     7.6.  This Agreement has been mutually prepared, negotiated and drafted by each of the parties
hereto and thereto. The parties agree that the terms of this Agreement shall be construed and
interpreted against each party in the same manner and that no such provisions shall be construed or
interpreted more strictly against one party on the assumption that an instrument is to be construed
more strictly against the party which drafted the agreement.

     7.7.  Any term or provision of this Agreement may be waived, or the time for its performance
may be extended, pursuant to a written action by the party or parties entitled to the benefit
thereof. Any such waiver shall be validly and sufficiently authorized for purposes of this
Agreement if, as to any party,

- 5 -

 

it is authorized in writing by an authorized representative of such party. The failure of any
party hereto to enforce at any time any provision of this Agreement shall not be construed to be a
waiver of such provision, nor in any way to affect the validity of this Agreement or any part
hereof or the right of any party thereafter to enforce each and every such provision. No waiver of
any breach of this Agreement shall be held to constitute a waiver of any other or subsequent
breach.

     7.8.  Except as specifically provided in Section 6 hereof, regardless of whether the
transactions provided for in this Agreement are consummated, each party hereto will pay its own
costs and expenses incident to the negotiation, preparation and performance of this Agreement,
including the fees, expenses and disbursements of its counsel, financial advisors, and accountants.

     7.9.  Wherever possible, each provision hereof shall be interpreted in such manner as to be
effective and valid under applicable law, but in case any one or more of the provisions contained
herein shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such
provision shall be ineffective to the extent, but only to the extent, of such invalidity,
illegality or unenforceability without invalidating the remainder of such invalid, illegal or
unenforceable provision or provisions or any other provisions hereof, unless such a construction
would be unreasonable.

     7.10.  This Agreement may be executed in one or more counterparts, each of which shall be
considered an original instrument, and shall become binding when one or more counterparts have been
signed by each of the parties hereto and delivered to each of the parties hereto.

     7.11.  This Agreement shall be governed by and construed in accordance with the internal laws
of the State of Texas, without giving effect to any choice of laws provisions that may direct the
application of the laws of another jurisdiction.

     7.12.  Each of the parties hereby: (a) agrees that any action arising out of or related to
this Agreement or any of the transactions contemplated hereby or thereby shall be filed and shall
proceed exclusively in the federal and state courts located in Dallas, Texas; (b) irrevocably
consents to jurisdiction in such courts; and (c) waives any and all objections to jurisdiction and
venue in such courts that they may have under the federal or state laws of the United States.

- 6 -

 

     7.13.  The provisions of this Agreement are intended for the sole benefit of the parties hereto
and shall not inure to the benefit of any other Person, other than successors and permitted assigns
of parties hereto, whether as third party or otherwise.

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above
written.

	 	 	 	 	 
	 	HealthMarkets, Inc.

 	 
	 	By:  	/s/ Glenn W. Reed
 	 
	 	Name:  	Glenn W. Reed	 
	 	Its:  	Executive Vice President 	 
	 

	 	 	 	 	 
	 	Special
Investment Risks, Limited,

a Texas limited partnership	 
	 	  	

 	 
	 	By:  	S.I.R.
Holding Corp., Inc.,
its general partner
 	 
	 	  	

 	 
	 	By:  	/s/
Jeffrey J. Jensen
 	 
	 	Name:  	Jeffrey J. Jensen 	 
	 	Its:  	President	 
	 

- 7 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}]]